These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3871315)

  • 1. Acute effect of smoking on the functional activity of alpha1-protease inhibitor in bronchoalveolar lavage fluid.
    Abboud RT; Fera T; Richter A; Tabona MZ; Johal S
    Am Rev Respir Dis; 1985 Jan; 131(1):79-85. PubMed ID: 3871315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effect of nitrogen dioxide exposure on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid of normal subjects.
    Mohsenin V; Gee JB
    Am Rev Respir Dis; 1987 Sep; 136(3):646-50. PubMed ID: 3498415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of smoking on elastaselike esterase activity and immunologic neutrophil elastase levels in bronchoalveolar lavage fluid.
    Fera T; Abboud RT; Richter A; Johal SS
    Am Rev Respir Dis; 1986 Apr; 133(4):568-73. PubMed ID: 3634579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of elastase activity in bronchoalveolar lavage fluids of healthy smokers and nonsmokers.
    Janoff A; Raju L; Dearing R
    Am Rev Respir Dis; 1983 May; 127(5):540-4. PubMed ID: 6552150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular elastolytic activity in human lung lavage: a comparative study between smokers and non-smokers.
    Smith SF; Guz A; Cooke NT; Burton GH; Tetley TD
    Clin Sci (Lond); 1985 Jul; 69(1):17-27. PubMed ID: 3905206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concentration of leukocyte elastase-alpha 1-proteinase inhibitor complex in bronchoalveolar lavage fluids from healthy human subjects.
    Jochum M; Pelletier A; Boudier C; Pauli G; Bieth JG
    Am Rev Respir Dis; 1985 Oct; 132(4):913-4. PubMed ID: 3876796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of concentrations of two proteinase inhibitors, porcine pancreatic elastase inhibitory capacity, and cell profiles in sequential bronchoalveolar lavage samples.
    Morrison HM; Kramps JA; Dijkman JH; Stockley RA
    Thorax; 1986 Jun; 41(6):435-41. PubMed ID: 3491440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional alpha 1-protease inhibitor in the lower respiratory tract of cigarette smokers is not decreased.
    Stone PJ; Calore JD; McGowan SE; Bernardo J; Snider GL; Franzblau C
    Science; 1983 Sep; 221(4616):1187-9. PubMed ID: 6612333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylene blue decreases the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage.
    Richter AM; Abboud RT; Johal SS
    Am Rev Respir Dis; 1986 Aug; 134(2):326-7. PubMed ID: 3488702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and immunoreactive alpha 1 proteinase inhibitor in bronchoalveolar lavages: methodological studies.
    el Yamani J; Hayem A; Lafitte JJ; Gressier B; Mizon J
    Bull Eur Physiopathol Respir; 1986; 22(4):359-63. PubMed ID: 3094607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional activity of alpha 1-proteinase inhibitor in bronchoalveolar lavage fluids from healthy human smokers and non-smokers.
    Boudier C; Pelletier A; Pauli G; Bieth JG
    Clin Chim Acta; 1983 Aug; 132(3):309-15. PubMed ID: 6604594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental pulmonary inflammatory injury in the monkey.
    Revak SD; Rice CL; Schraufstätter IU; Halsey WA; Bohl BP; Clancy RM; Cochrane CG
    J Clin Invest; 1985 Sep; 76(3):1182-92. PubMed ID: 2995448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of smoking on functional activity of plasma alpha 1-protease inhibitor.
    Fera T; Abboud RT; Johal SS; Richter AM; Gibson N
    Chest; 1987 Mar; 91(3):346-50. PubMed ID: 3493119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrapulmonary half-life and safety of aerosolized alpha1-protease inhibitor in normal volunteers.
    Vogelmeier C; Kirlath I; Warrington S; Banik N; Ulbrich E; Du Bois RM
    Am J Respir Crit Care Med; 1997 Feb; 155(2):536-41. PubMed ID: 9032191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1-antitrypsin content in the serum, alveolar macrophages, and alveolar lavage fluid of smoking and nonsmoking normal subjects.
    Olsen GN; Harris JO; Castle JR; Waldman RH; Karmgard HJ
    J Clin Invest; 1975 Feb; 55(2):427-30. PubMed ID: 1079211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid.
    Cochrane CG; Spragg R; Revak SD
    J Clin Invest; 1983 Mar; 71(3):754-61. PubMed ID: 6600748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of alpha 1-proteinase inhibitor by alveolar inflammatory cells from smoking patients with or without emphysema.
    Wallaert B; Gressier B; Marquette CH; Gosset P; Remy-Jardin M; Mizon J; Tonnel AB
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1537-43. PubMed ID: 8389110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional activity of the alpha1-proteinase inhibitor in serum and bronchoalveolar lavage fluid in congenital lung emphysema].
    Trefz G; Heck B; Schulz V; Ebert W
    Pneumologie; 1989 Aug; 43(8):446-51. PubMed ID: 2788886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antiproteases in smokers and nonsmokers. Relationships to smoking status and pulmonary function.
    Bridges RB; Kimmel DA; Wyatt RJ; Rehm SR
    Am Rev Respir Dis; 1985 Dec; 132(6):1162-9. PubMed ID: 3878111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoalveolar lavage in patients with interstitial lung diseases: side effects and factors affecting fluid recovery.
    Dhillon DP; Haslam PL; Townsend PJ; Primett Z; Collins JV; Turner-Warwick M
    Eur J Respir Dis; 1986 May; 68(5):342-50. PubMed ID: 3732429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.